Factors Associated with Herpes Simplex Virus Type 2 Incidence in a Cohort of Human Immunodeficiency Virus Type 1-seronegative Kenyan Men and Women Reporting High-risk Sexual Behavior
Overview
Authors
Affiliations
Background: Herpes simplex virus type 2 (HSV-2) is an important cause of genital ulcers and can increase the risk for human immunodeficiency virus type 1 (HIV-1) transmission. Our objective was to determine the incidence and correlates of HSV-2 infection in HIV-1-seronegative Kenyan men reporting high-risk sexual behavior, compared with high-risk HIV-1-seronegative women in the same community.
Methods: Cohort participants were screened for prevalent HIV-1 infection. HIV-1-uninfected participants had regularly scheduled follow-up visits, with HIV counseling and testing and collection of demographic and behavioral data. Archived blood samples were tested for HSV-2.
Results: HSV-2 prevalence was 22.0% in men and 50.8% in women (P < 0.001). HSV-2 incidence in men was 9.0 per 100 person-years, and was associated with incident HIV-1 infection (adjusted incidence rate ratio [aIRR], 3.9; 95% confidence interval [CI], 1.3-12.4). Use of soap for genital washing was protective (aIRR, 0.3; 95% CI, 0.1-0.8). Receptive anal intercourse had a borderline association with HSV-2 acquisition in men (aIRR, 2.0; 95% CI, 1.0-4.1; P = 0.057), and weakened the association with incident HIV-1. Among women, HSV-2 incidence was 22.1 per 100 person-years (P < 0.001 compared with incidence in men), and was associated with incident HIV-1 infection (aIRR, 8.9; 95% CI, 3.6-21.8) and vaginal washing with soap (aIRR, 1.9; 95% CI, 1.0-3.4).
Conclusions: HSV-2 incidence in these men and women is among the highest reported, and is associated with HIV-1 acquisition. Although vaginal washing with soap may increase HSV-2 risk in women, genital hygiene may be protective in men.
Mugo N, Stalter R, Heffron R, Rees H, Scoville C, Morrison C Clin Infect Dis. 2021; 75(4):586-595.
PMID: 34910143 PMC: 9464069. DOI: 10.1093/cid/ciab1027.
Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa.
Lazarus E, Otwombe K, Dietrich J, Andrasik M, Morgan C, Kublin J South Afr J HIV Med. 2019; 20(1):866.
PMID: 31308962 PMC: 6620501. DOI: 10.4102/sajhivmed.v20i1.866.
Maughan-Brown B, George G, Beckett S, Evans M, Lewis L, Cawood C Sex Transm Infect. 2019; 95(6):443-448.
PMID: 30737260 PMC: 7477752. DOI: 10.1136/sextrans-2018-053577.
Akinyi B, Odhiambo C, Otieno F, Inzaule S, Oswago S, Kerubo E PLoS One. 2017; 12(6):e0178907.
PMID: 28586396 PMC: 5460811. DOI: 10.1371/journal.pone.0178907.
Daniels B, Wand H, Ramjee G BMC Res Notes. 2016; 9(1):510.
PMID: 27955706 PMC: 5154041. DOI: 10.1186/s13104-016-2319-5.